(Q30471258)

22 September 2017

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

22 September 2017

0 references

1 reference

1 reference

17

Toshikazu Yoshikawa

1 reference

22 September 2017

2

Masato Yoneda

1 reference

22 September 2017

12

Kazuaki Chayama

1 reference

22 September 2017

3

Hideyuki Hyogo

1 reference

22 September 2017

Yoshio Sumida

1

1 reference

22 September 2017

Yoshito Itoh

4

1 reference

22 September 2017

Masafumi Ono

5

1 reference

22 September 2017

Hideki Fujii

6

1 reference

22 September 2017

Yuichiro Eguchi

7

1 reference

22 September 2017

Yasuaki Suzuki

8

1 reference

22 September 2017

Noriaki Aoki

9

1 reference

22 September 2017

Kazuyuki Kanemasa

10

1 reference

22 September 2017

Koji Fujita

11

1 reference

22 September 2017

Toshiji Saibara

13

1 reference

22 September 2017

Norifumi Kawada

14

1 reference

22 September 2017

Kazuma Fujimoto

15

1 reference

22 September 2017

Yutaka Kohgo

16

1 reference

22 September 2017

Takeshi Okanoue

18

1 reference

22 September 2017

Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)

19

1 reference

22 September 2017

5 January 2012

1 reference

22 September 2017

1 reference

22 September 2017

12

1 reference

22 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-230x-12-2

22 September 2017

0 references

cites work

Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Non-alcoholic steatohepatitis with normal aminotransferase values

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Liver fibrosis in overweight patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Long-term follow-up of patients with nonalcoholic fatty liver

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266187

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

26 November 2018

1 reference

12 December 2020

Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

1 reference

12 December 2020

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

1 reference

12 December 2020

Applicability of BARD score to Japanese patients with NAFLD

1 reference

12 December 2020

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-12-2

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference

22 September 2017

1 reference